Simplex Trading, LLC Arcus Biosciences, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 10,740 shares of RCUS stock, worth $166,470. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,740

Previous 129,860 91.73%

Holding current value

$166,470

Previous $1.98 Million 91.7%

% of portfolio

0.01%

Previous 0.07%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$13.69 - $18.01 $1.63 Million - $2.15 Million	-119,120 Reduced 91.73%	10,740 $164,000
Q2 2024 Jul 25, 2024	BUY	$14.59 - $18.48 $1.75 Million - $2.22 Million	120,137 Added 1235.6%	129,860 $1.98 Million
Q1 2024 Apr 25, 2024	SELL	$14.83 - $20.18 $1.15 Million - $1.56 Million	-77,361 Reduced 88.83%	9,723 $183,000
Q4 2023 Feb 02, 2024	BUY	$13.43 - $19.63 $30,768 - $44,972	2,291 Added 2.7%	87,084 $1.66 Million
Q3 2023 Nov 01, 2023	SELL	$17.62 - $23.54 $700,359 - $935,667	-39,748 Reduced 31.92%	84,793 $1.52 Million
Q2 2023 Aug 04, 2023	BUY	$16.97 - $22.03 $1.97 Million - $2.55 Million	115,943 Added 1348.49%	124,541 $2.53 Million
Q1 2023 Apr 27, 2023	BUY	$15.96 - $23.15 $137,224 - $199,043	8,598 New	8,598 $156,000
Q2 2022 Aug 03, 2022	SELL	$17.23 - $37.73 $3,359 - $7,357	-195 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$28.92 - $41.83 $579,614 - $838,356	-20,042 Reduced 99.04%	195 $6,000
Q3 2021 Oct 28, 2021	BUY	$26.93 - $37.68 $2,693 - $3,768	100 Added 0.5%	20,237 $557,000
Q2 2021 Aug 12, 2021	BUY	$22.75 - $35.77 $458,116 - $720,300	20,137 New	20,137 $552,000
Q1 2021 Apr 26, 2021	SELL	$26.16 - $41.39 $647,957 - $1.03 Million	-24,769 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$17.0 - $32.36 $421,073 - $801,524	24,769 New	24,769 $643,000
Q4 2019 Feb 05, 2020	SELL	$7.33 - $10.79 $417 - $615	-57 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$6.44 - $10.18 $367 - $580	57 New	57 $0

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.12B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Arcus Biosciences, Inc. Transaction History